Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global PDT Market Portraiture
2.2. Global PDT Market, by Type of Drug Class, 2018 (US$ Mn)
2.3. Global PDT Market, by Geography, 2018 Vs 2027 (Value %)
Chapter 3. Global Paget’s Disease Treatment (PDT) Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2018
3.6. Competitive Landscape
3.6.1. Competitive Landscape, by Key Players, 2018
Chapter 4. Global Paget’s Disease Treatment (PDT) Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
4.1. Overview
4.2. Bisphosphonates
4.2.1. Zoledronic acid
4.2.2. Pamidronate Disodium
4.2.3. Etidronate
4.2.4. Tiludronate
4.2.5. Alendronate
4.2.6. Risedronate
4.3. Calcitonin Analogues (Salmon Calcitonin)
4.4. Analgesics
4.5. Calcium & Vitamin D Supplements
Chapter 5. Global Paget’s Disease Treatment (PDT) Market, by Geography, 2017 – 2027 (US$ Mn)
5.1. Overview
5.2. North America PDT Market Analysis, 2017 – 2027
5.2.1. North America PDT Market, by Type of Drug Class, 2017–2027 (US$ Mn)
5.2.2. North America PDT Market, by Country, 2017 – 2027 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe PDT Market Analysis, 2017 – 2027
5.3.1. Europe PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
5.3.2. Europe PDT Market, by Country, 2017 – 2027 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific PDT Market Analysis, 2017 – 2027
5.4.1. Asia Pacific PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
5.4.2. Asia Pacific PDT Market, by Country, 2017 – 2027 (US$ Mn)
5.4.2.1. Japan
5.4.2.2. China
5.4.2.3. Rest of APAC
5.5. Latin America PDT Market Analysis, 2017 – 2027
5.5.1. Latin America PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
5.5.2. Latin America PDT Market, by Country, 2017 – 2027 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa (MEA) PDT Market Analysis, 2017 – 2027
5.6.1. Middle East & Africa PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
5.6.2. MEA PDT Market, by Region, 2017 – 2027 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA
Chapter 6. Company Profiles
6.1. Novartis AG
6.1.1. Business Description
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. Key Developments
6.2. Merck & Co., Inc.
6.3. Neopharma, Inc.
6.4. Sanofi SA
6.5. Allergan Pharmaceuticals International Ltd.
6.6. Fresenius Kabi
6.7. F.Hoffman La-Roche
6.8. Areva Pharmaceuticals, Inc.
6.9. Mallinckrodt, Inc.
6.10. Teva Pharmaceutical Industries Ltd.
6.11. Mylan Pharmaceuticals, Inc.
6.12. Sun Pharmaceutical Industries, Ltd.
List of Figures
FIG. 1 Paget’s Disease Treatment (PDT): Market Segmentation
FIG. 2 Global PDT Market, by Type of Drug Class, 2018 (US$ Mn)
FIG. 3 Global PDT Market, by Geography, 2018 Vs 2027 (US$ Mn)
FIG. 4 Attractive Investment Proposition, by Geography, 2018
FIG. 5 Market Competition Landscape, by Key Players, 2018
FIG. 6 Global Zoledronic Acid Market for PDT, 2017 – 2027 (US$ Mn)
FIG. 7 Global Pamidronate Disodium Market for PDT, 2017 – 2027 (US$ Mn)
FIG. 8 Global Etidronate Market for PDT, 2017 – 2027 (US$ Mn)
FIG. 9 Global Tiludronate Market for PDT Market, 2017 – 2027 (US$ Mn)
FIG. 10 Global Alendronate Market for PDT Market, 2017 – 2027 (US$ Mn)
FIG. 11 Global Risedronate Market for PDT, Till 2027 (US$ Mn)
FIG. 12 Global Calcitonin Analogues Market for PDT, Till 2027 (US$ Mn)
FIG. 13 Global Analgesics Market for PDT, Till 2027 (US$ Mn)
FIG. 14 Global Calcium & Vitamin D Supplements Market for PDT, Till 2027 (US$ Mn)
FIG. 15 U.S. PDT Market, 2017 – 2027 (US$ Mn)
FIG. 16 Canada PDT Market, 2017 – 2027 (US$ Mn)
FIG. 17 U.K. PDT Market, 2017 – 2027 (US$ Mn)
FIG. 18 Germany PDT Market, 2017 – 2027 (US$ Mn)
FIG. 19 Rest Of Europe PDT Market, 2017 – 2027 (US$ Mn)
FIG. 20 Japan PDT Market, 2017 – 2027 (US$ Mn)
FIG. 21 China PDT Market, 2017 – 2027 (US$ Mn)
FIG. 22 Rest Of Asia Pacific PDT Market, 2017 – 2027 (US$ Mn)
FIG. 23 Brazil PDT Market, 2017 – 2027 (US$ Mn)
FIG. 24 Mexico PDT Market, 2017 – 2027 (US$ Mn)
FIG. 25 Rest Of Latin America PDT Market, 2017 – 2027 (US$ Mn)
FIG. 26 GCC PDT Market, 2017 – 2027 (US$ Mn)
FIG. 27 Rest Of Middle East And Africa PDT Market, 2017 – 2027 (US$ Mn)
List of Tables
TABLE 1 Global Paget’s Disease Treatment (PDT) Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 2 North America PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 3 North America PDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 4 Europe PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 5 Europe PDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 6 Asia Pacific PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 7 Asia Pacific PDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 8 Latin America PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 9 Latin America PDT Market, by Country/Region, 2017 – 2027 (US$ Mn)
TABLE 10 Middle East & Africa PDT Market, by Type of Drug Class, 2017 – 2027 (US$ Mn)
TABLE 11 Middle East And Africa PDT Market, by Region, 2017 – 2027 (US$ Mn)
TABLE 12 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 13 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Neopharma, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Sanofi SA: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Allergan Pharmaceuticals International Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Fresenius Kabi: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 F.Hoffman La-Roche: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Areva Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Mallinckrodt, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Mylan Pharmaceuticals, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Sun Pharmaceutical Industries, Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)